Initial Experience with a New Ureteral Stent for Malignant Obstruction
Author Information
Author(s): Lee Chung Un, Choo Seol Ho, Chung Jae Hoon, Han Deok Hyun
Primary Institution: Samsung Medical Center
Hypothesis
This study aimed to investigate initial experiences and outcomes of a retrograde inserted new silicone-covered metallic ureteric stent (Urexel™) for malignant ureteric obstruction.
Conclusion
The Urexel™ stent provided acceptable success and complication rates in patients with malignant ureteric obstructions.
Supporting Evidence
- The 6-month success rate was 83.3%, and the 1-year success rate was 70%.
- Stent migration was observed in 23.1% of cases.
- Common complications included persistent pain and acute pyelonephritis.
Takeaway
Doctors tested a new type of stent to help people with blocked ureters due to cancer, and it worked pretty well.
Methodology
The study reviewed medical records of 12 patients who underwent Urexel™ stent placement for malignant ureteric obstruction.
Limitations
The study was retrospective with a small sample size and insufficient follow-up period.
Participant Demographics
The median age of patients was 61.5 years, with 3 males and 9 females.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website